Hypertension Clinical Trials

Find Hypertension Clinical Trials Near You

Impact of Dietary Fiber-Rich Kodo Millet Porridge Supplementation on Gut Microbiome and Metabolic Syndrome

Status: Recruiting
Location: See location...
Intervention Type: Dietary supplement
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Dietary fiber are components in foods that are not digested by human gastrointestinal enzymes (alpha amylase and alpha glucosidase) but are instead broken down and fermented by gut microbes. The byproducts generated during fermentation in the large intestine, primarily short-chain fatty acids (SCFA), bile acids, indoles, and their derivatives, circulate through the circulatory system to the liver, lungs, brain, adipose tissue, and muscles, where they modulate metabolism (suppress lipogenesis and alleviate insulin resistance) and immune function. Individuals who are overweight or obese frequently exhibit gut dysbiosis, characterized by lower SCFA producing commensals. This condition predisposes them to metabolic disorders such as insulin resistance, dyslipidemia, and hypertension, and contributes to conditions including type 2 diabetes, cardiovascular disease, and metabolic dysfunction-associated steatotic liver disease. Preclinical and clinical research have demonstrated that the consumption of fiber-rich foods maintains or restores gut microbiota health and diminishes the risk of metabolic disorders. Kodo millet (Paspalum scrobiculatum), a small millet, is rich in dietary fiber and we have developed a palatable kodo millet porridge beverage enriched with polyphenols and dietary fiber. The purpose of this study is to examine the effects of consuming Kodo millet porridge beverage as a nutritional supplement for 3 months, on gut microbiome richness (composition and diversity) and metabolic health in overweight or obese people.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 20
Maximum Age: 60
Healthy Volunteers: f
View:

• Adults aged 20-60 years.

• Willingness to provide informed consent.

• Willingness to consume Kodo millet porridge daily for 12 weeks.

• No planned changes in diet or physical activity during the study.

• Overweight or obese (BMI ≥ 25 kg/m²), placing them at risk for metabolic disorders.

Locations
Other Locations
India
JSS Medical College, JSS Academy of Higher Education & Research(JSSAHER).
RECRUITING
Mysore
Contact Information
Primary
Prerana Shridhar Bhat, MSc
preranabhat@jssuni.edu.in
+918762399079
Backup
Dr. Rajesh Kumar Thimmulappa, PhD
rajeshkt@jssuni.edu.in
+91-9972012892
Time Frame
Start Date: 2026-06-01
Estimated Completion Date: 2026-11-16
Participants
Target number of participants: 50
Treatments
Experimental: Kodo Millet Porridge Intervention
Participants consume 200 ml of Kodo millet porridge (5% Kodo millet by weight) daily for 12 weeks, 6 days per week, served at 10-11 AM
Sponsors
Leads: JSS MEDICAL COLLEGE, JSS ACADEMY OF HIGHER EDUCATION AND RESEARCH

This content was sourced from clinicaltrials.gov